NCT01661868 Olaparib for Patients With Recurrent BRCA Deficient Ovarian Cancer Status WITHDRAWN Phase PHASE2
NCT01659606 Radiation- and Alkylator-free Bone Marrow Transplantation Regimen for Patients With Dyskeratosis Congenita Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01647607 Young and Strong: An Education and Supportive Care Intervention Study for Young Women With Breast Cancer Status COMPLETED Phase NA
NCT01642186 Study of (1) Everolimus, (2) Estrogen Deprivation Therapy (EDT) With Leuprolide + Letrozole and (3) Everolimus + EDT in Patients With Unresectable Fibrolamellar Hepatocellular Carcinoma (FLL-HCC) Status COMPLETED Phase PHASE2
NCT01629615 A Trial of BKM120 (a PI3K Inhibitor) in Patients With Triple Negative Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT01623349 Phase I Study of the Oral PI3kinase Inhibitor BKM120 or BYL719 and the Oral PARP Inhibitor Olaparib in Patients With Recurrent Triple Negative Breast Cancer or High Grade Serous Ovarian Cancer Status COMPLETED Phase PHASE1
NCT01600807 OSI-906 With Gemcitabine and Erlotinib for Metastatic Ductal Adenocarcinoma of the Pancreas Status WITHDRAWN Phase PHASE1/PHASE2
NCT01596322 International HIV Antiretroviral Adherence, Resistance and Survival Status COMPLETED Phase N/A
NCT01586182 Stereotactic Boost for Oropharyngeal Squamous Cell Carcinoma Status WITHDRAWN Phase PHASE1/PHASE2
NCT01582841 Integrating Genetic Testing for Lynch Syndrome in a Managed Care Setting Status COMPLETED Phase NA
NCT01579552 Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT01574274 SC-PEG Asparaginase vs. Oncaspar in Pediatric Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT01568346 Breast MRI for Newly Diagnosed Breast Cancer:Impact on Re-excision Lumpectomy Status TERMINATED Phase PHASE3